uBriGene and YolTech Therapeutics Join Forces to Advance mRNA Therapy and Gene Therapy
China-based uBriGene Biosciences Inc., a prominent contract development and manufacturing organization (CDMO) specializing in cell...
CDE’s 2022 Drug Review Report: A Year of Pandemic Response and Regulatory Milestones
The Center for Drug Evaluation (CDE) has released its comprehensive 2022 annual drug review report,...
Hainan Haiyao Concludes Phase I Clinical Study for PaiEnJiaBin, a Novel KCNQ Agonist
China-based Hainan Haiyao Co., Ltd (SHE: 000566) has announced the conclusion of Phase I clinical...
Sino Medical Sciences Technology to Acquire Majority Stake in US Endovascular Device Firm eLum
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced plans to acquire a 72.73%...
Acotec Scientific Holdings Receives Marketing Approvals for Vericor-14 Microcatheter in Japan and Thailand
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received marketing approvals...
Brii Biosciences Announces Positive Interim Data for BRII-179 Vaccine in Chronic Hepatitis B
China-based Brii Biosciences Ltd (HKG: 2137) has announced topline cohort-level unblinded Week 36 data from...
MSD’s Gardasil 9 HPV Vaccine Demonstrates 10-Year Efficacy in Adolescents
Merck, Sharp & Dohme (MSD; NYSE: MRK) has released long-term effectiveness data for its recombinant...
Sinovac Biotech Directors Reject Alternative Liquidity’s Lowball Tender Offer
China-based Sinovac Biotech Ltd. (NASDAQ: SVA) announced that its Board of Directors has unanimously determined...
Abbott to Acquire Insulin Management Firm Bigfoot Biomedical
Healthcare giant Abbott (NYSE: ABT) has announced an agreement to purchase Bigfoot Biomedical, a company...
Taizhou Port Designated as Drug Import Port by NMPA and General Administration of Customs
The National Medical Products Administration (NMPA) and the General Administration of Customs have released a...
Sandoz Reports H1 2023 Financials with 8% YOY Growth, Separation from Novartis Looms
Switzerland-based Sandoz (SWX: SDZ) has published its financial statements for the first half of 2023,...
Li Li Appointed as New Director of NMPA
The State Council has released an announcement regarding appointments and dismissals within the government. Among...
NHSA Mandates National Standards for Medical Consumables in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification with a focus on enhancing...
Bristol-Myers Squibb Acquires Rights to Zenas BioPharma’s Obexelimab for Autoimmune Diseases
US pharmaceutical major Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a licensing and cooperation...
Neurophth Biotechnology’s NFS-05 Gene Therapy Gets Australian Clinical Trial Approval for ADOA
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced that it has received clinical trial...
MGI Tech Partners with Eight Companies to Expand G99-Based Sequencing Applications
China-based MGI Tech, a subsidiary of BGI Group (SHE: 300676), has entered into cooperation agreements...
Harbin Gloria Pharmaceuticals’ Zimberelimab Receives NMPA Approval for Cervical Cancer Treatment
China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) has announced that it has received market...
Janssen Appoints Cherry Huang as President of Xi’an Janssen in China Management Shake-Up
The Janssen unit of Johnson & Johnson (J&J; NYSE: JNJ) has announced a significant management...
Seagen and Genmab Announce Positive Phase III Results for Tivdak in Cervical Cancer
Seagen (NASDAQ: SGEN), currently in the process of being acquired by Pfizer (NYSE: PFE), and...
SinoMab BioScience’s Suciraslimab Files for Market Approval in China for Rheumatoid Arthritis
Hong Kong-based biotech company SinoMab BioScience Ltd (HKG: 3681) has announced that a market approval...